WA
ACAD icon

WPG Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

WPG Advisers’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.81K Buy
190
+86
+83% +$1.89K ﹤0.01% 983
2026
Q1 		$2.31K Buy
104
+1
+1% +$24 ﹤0.01% 1051
2025
Q4 		$2.75K Sell
103
-30
-23% -$717 ﹤0.01% 1046
2025
Q3 		$2.84K Hold
133
– – ﹤0.01% 1051
2025
Q2 		$2.87K Buy
133
+65
+96% +$1.21K ﹤0.01% 1030
2025
Q1 		$1.13K Sell
68
-38
-36% -$690 ﹤0.01% 1228
2024
Q4 		$1.95K Buy
+106
New +$1.71K ﹤0.01% 1084

Other funds holding ACAD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WPG Advisers's ACAD Position: Q2 2026 in Review

WPG Advisers increased its Acadia Pharmaceuticals (ACAD) stake by 83% in Q2 2026, buying an estimated $1.89K and bringing the position to 190 shares worth $4.81K. The position accounts for ﹤0.01% of the portfolio, ranked #983.

WPG Advisers first reported a position in ACAD in Q4 2024 and has held it in 7 quarters since. 138 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • WPG Advisers held 190 shares of Acadia Pharmaceuticals worth $4.81K as of Q2 2026.
  • WPG Advisers bought 86 Acadia Pharmaceuticals shares in Q2 2026, an estimated $1.89K.
  • Acadia Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #983 holding.
  • WPG Advisers first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 138 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.